Evidence map›Paper›PMID 34523966›Full record

ArticleJournal of virology2021

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.

Benjamin E Nilsson-Payant, Skyler Uhl, Adrien Grimont, Ashley S Doane, Phillip Cohen, Roosheel S Patel, Christina A Higgins, Joshua A Acklin, Yaron Bram, Vasuretha Chandar and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Review
  3. Unique nasal cell states induced by common pediatric respiratory viruses.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Benjamin E Nilsson-Payant *Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0003-2661-7837
Skyler Uhl *Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0001-8517-1455
Adrien GrimontDepartment of Surgery, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0003-1998-580X
Ashley S DoaneDepartment of Physiology and Biophysics, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0002-1489-1786
Phillip CohenDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-9368-5154
Roosheel S PatelDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-0683-6920
Christina A HigginsDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-9865-148X
Joshua A AcklinDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-4203-2428
Yaron BramDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0001-9711-575X
Vasuretha ChandarDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0001-8631-3347
Daniel Blanco-MeloDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-0256-5019
Maryline PanisDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Jean K LimDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.
Olivier ElementoDepartment of Physiology and Biophysics, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0002-8061-9617
Robert E SchwartzDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0002-5417-5995
Brad R RosenbergDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0002-5885-1276
Rohit ChandwaniDepartment of Surgery, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.ORCID 0000-0003-4781-6069
Benjamin R tenOeverDepartment of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.ORCID 0000-0003-0324-3078
Icahn School of Medicine at Mount Sinai · USCornell University · US

Funding

TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Next Generation Resolution of Antiviral Gene NetworksR01AI151029 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Dusan Bogunovic, Brad Rosenberg · 2020 to 2026
$4.2M
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyteR01DK121072 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2020 to 2024
$2.6M
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodiesR01AI150837 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2020 to 2024
$2.1M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Bill and Melinda Gates Foundation (BMGF)Foundation for the National Institutes of Health (FNIH) AI151029-01A1NIAID NIH HHS R01 AI150837NIAID NIH HHS R01 AI151029NIAID NIH HHS T32 AI007647NIDDK NIH HHS R01 DK121072NIH HHS S10 OD026880
6 · The paper itself

Abstract

SARS-CoV-2, the etiological agent of COVID-19, is characterized by a delay in type I interferon (IFN-I)-mediated antiviral defenses alongside robust cytokine production. Here, we investigate the underlying molecular basis for this imbalance and implicate virus-mediated activation of NF-κB in the absence of other canonical IFN-I-related transcription factors. Epigenetic and single-cell transcriptomic analyses show a selective NF-κB signature that was most prominent in infected cells. Disruption of NF-κB signaling through the silencing of the NF-κB transcription factor p65 or p50 resulted in loss of virus replication that was rescued upon reconstitution. These findings could be further corroborated with the use of NF-κB inhibitors, which reduced SARS-CoV-2 replication

Indexed as

SARS-CoV-2TranscriptomeVirus ReplicationA549 CellsAnimalsChlorocebus aethiopsCOVID-19CytokinesEpigenomicsGene Expression RegulationHEK293 CellsHeLa CellsHost Microbial InteractionsHumansInterferon Type ISignal TransductionCytokinesInterferon Type IRELA protein, humanTranscription Factor RelATranscription FactorsNF-κBSARS-CoV-2

Identifiers

PMID34523966
PMCPMC8577386
OpenAlexW3199167353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.